T8	Treatment 166 250	a seven-month use of recombinant interferon alpha-2a for chronic active hepatitis C.
T9	Subject 8 27	a 62-year-old woman
T10	Effect 39 159	bilateral optic neuritis with decreased sensation of vibration and increased deep tendon reflex in the lower extremities
T11	Age 10 21	62-year-old
T12	Gender 22 27	woman
T13	Time_elapsed 166 179	a seven-month
T14	Drug 187 218	recombinant interferon alpha-2a
T15	Treat-Disorder 223 249	chronic active hepatitis C
T7	Adverse_event 160 165	after
E1	Adverse_event:T7 
